Comment Period Extended to 3/23/2015 for Notice of Proposed Rulemaking (NPRM) for FDAAA 801 and NIH Draft Reporting Policy for NIH-Funded Trials
2 studies found for:    10467384 [PUBMED-IDS]
Show Display Options
Rank Status Study
1 Recruiting Assessment of Clemastine Fumarate as a Remyelinating Agent in Multiple Sclerosis
Condition: Multiple Sclerosis, Relapsing-Remitting
Interventions: Drug: Clemastine;   Drug: Placebo
2 Completed Lokomat Treadmill Training Effects on MS Gait
Conditions: Gait, Unsteady;   Multiple Sclerosis
Intervention: Other: Body-weight supported treadmill training +/- Lokomat assistance

Indicates status has not been verified in more than two years